PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea
Status:
Completed
Trial end date:
2019-12-19
Target enrollment:
Participant gender:
Summary
The investigators aim is to investigate the incidence of headache and rosacea-like flushing
after pituitary adenylate cyclase-activating peptide-38 (PACAP38) with and without treatment
with sumatriptan in patients with rosacea